Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative - Giorgi Rossi, P; Lebeau, A; Canelo-Aybar, C (Br J Cancer, 2021)